Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The cellular activity of several regulatory and signal transduction proteins, which depend on the Hsp90 molecular chaperone for folding, is markedly decreased by geldanamycin and by radicicol (monorden). We now show that these unrelated compounds both bind to the N-terminal ATP/ADP-binding domain of Hsp90, with radicicol displaying nanomolar affinity, and both inhibit the inherent ATPase activity of Hsp90 which is essential for its function in vivo. Crystal structure determinations of Hsp90 N-terminal domain complexes with geldanamycin and radicicol identify key aspects of their nucleotide mimicry and suggest a rational basis for the design of novel antichaperone drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Self-citationDynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4829 · Cited by 735
Self-citationGrenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., Binart, N., Mester, J., & Baulieu, E.-E. (1984) · Nature · doi:10.1038/308850a0 · Cited by 434
Research works printed but not linked: 15
- Kwon H. J., 1992, Biosci. Biotechnol. Biochem., 56, 539
- Zhao J. F., 1995, Oncogene, 11, 173
- Kwon H. J., 1995, J. Biochem., 118, 228
- Fukazawa H., 1991, Biochem. Pharmacol., 42, 1671
- Smith D. F., 1995, Mol. Cell. Biol., 15, 6812
- Whitesell L., 1996, Endocrinology, 10, 712
- Ali J. A., 1993, Biochemistry, 32, 2724
- Cutler H. G., 1987, Agric. Biol. Chem., 51, 3338
- Schnur R. C., 1995, J. Med. Chem., 38, 3820
- Schnur R. C., 1995, J. Med. Chem., 38, 3812
- Hartmann F., 1997, Int. J. Cancer, 70, 229, 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l
- Dai K., 1996, J. Biol. Chem., 271, 22034
- Whitesell L., 1992, Cancer Res., 52, 1728
- Prodromou C., 1996, PROTEINS: Struct. Funct. Genet., 25, 522
- Merrit E. A., 1994, Acta Crystallogr., 50, 873
Cited by
Items 801–900 of 1,000
Promotion of Hyperthermic-Induced rDNA Hypercondensation in Saccharomyces cerevisiae
Shen, D., & Skibbens, R. V. (2020) · Genetics · doi:10.1534/genetics.119.302994 · Cited by 6
7-aminocephalosporanic acid, a novel HSP90β inhibitor, attenuates HFD-induced hepatic steatosis
Zhang, W., Xue, H., Zhou, C., Zheng, Z., Xing, M., Chu, H., Li, P., Zhang, N., Dang, Y., & Xu, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.07.033 · Cited by 5
Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design
Moroni, E., Morra, G., & Colombo, G. (2012) · Pharmaceuticals · doi:10.3390/ph5090944 · Cited by 5
Molecular Chaperone Inhibitors
Moses, M. A., Zuehlke, A. D., & Neckers, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-69042-1_2 · Cited by 8
Arba, M., Ruslin, R., Kartasasmita, R. E., SURANTAATMADJA, S. I., & Tjahjono, D. H. (2018) · Journal of Mathematical and Fundamental Sciences · doi:10.5614/j.math.fund.sci.2018.50.3.6 · Cited by 5
Selective targeting of cancer cells using a hydrogen peroxide-activated Hsp90 inhibitor
Oh, Y. J., Park, S. Y., & Seo, Y. H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105195 · Cited by 5
Modulation of Specialized Metabolite Production in Genetically Engineered Streptomyces pactum
Ju, Z., Zhou, W., Alharbi, H. A., Howell, D. C., & Mahmud, T. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00718 · Cited by 5
Cheng, Y.-J., Lee, F.-W., Tsai, Y.-S., & Kuan, Y.-C. (2023) · Postharvest Biology and Technology · doi:10.1016/j.postharvbio.2023.112474 · Cited by 5
Anti-Inflammatory Activity of Geldanamycin and Its Derivatives in LPS-Induced RAW 264.7 Cells
Taechowisan, T., Puckdee, W., Waratchareeyakul, W., & Phutdhawong, W. S. (2019) · Advances in Microbiology · doi:10.4236/aim.2019.94024 · Cited by 5
Kumar, A., Rai, A., Rangra, N. K., Singh, T. G., Ugwuagbo, S. C., & Bhatia, R. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11314-3 · Cited by 4
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
Zarguan, I., Abbou, H., Zegrari, R., Festali, R., Buchanan, D., Benjouad, A., & Belayachi, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412150 · Cited by 4
Zierer, B. K., Weiwad, M., Rübbelke, M., Freiburger, L. A., Fischer, G. S., Lorenz, O., Sattler, M., Richter, K., & Büchner, J. (2014) · Angewandte Chemie · doi:10.1002/ange.201406578 · Cited by 4
Nair, A. M., Jiang, T., Mu, B., & Zhao, R. (2024) · Plants · doi:10.3390/plants13091265 · Cited by 4
Fernandez-Ciruelos, B., Albanese, M., Adhav, A. S., Solomin, V. V., Ritchie-Martinez, A., Taverne, F. J., Velikova, N., Jirgensons, A., Marina, A., Finn, P. W., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00146-24 · Cited by 4
Augello, M. A., Shadan, N., D’Amico, G., Barone, R., Bavisotto, C. C., Scalia, F., & Vitale, A. M. (2025) · Cells · doi:10.3390/cells14181447 · Cited by 4
Geldanamycin Enhances Retrograde Transport of Shiga Toxin in HEp-2 Cells
Lingelem, A. B. D., Ailte, I., Simm, R., Torgersen, M. L., & Sandvig, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129214 · Cited by 4
Verkhivker, G. M. (2014) · Israel Journal of Chemistry · doi:10.1002/ijch.201300143 · Cited by 4
Dynamic Docking of Macrocycles in Bound and Unbound Protein Structures with DynaDock
Meixner, M., Zachmann, M., Metzler, S., Scheerer, J., Zacharias, M., & Antes, I. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00436 · Cited by 4
Schmauder, L., & Richter, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-91690-6 · Cited by 4
Zhang, X. Z., Dai, L., Wu, Z., Jian, J., & Lu, Y. (2011) · Journal of Fish Biology · doi:10.1111/j.1095-8649.2011.03012.x · Cited by 4
Kim, J., Song, H., & Park, S. B. (2011) · Chemistry - An Asian Journal · doi:10.1002/asia.201100145 · Cited by 4
Kozeko, L. (2013) · Cytology and Genetics · doi:10.3103/s0095452713020072 · Cited by 4
Xu, X., Sun, H., Liu, F., Jia, J., Guo, X., Pan, Y., Huang, H., Zhang, X., & You, Q. (2014) · Molecular Informatics · doi:10.1002/minf.201300150 · Cited by 4
HSF1 Activation by Small Chemical Compounds for the Treatment of Neurodegenerative Diseases
Fujikake, N., Takeuchi, T., & Nagai, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-55852-1_14 · Cited by 4
Could Targeting the Heat Shock Protein 90 Revolutionize Antiviral therapy?
Wang, Y., Jin, F., Li, F., Qin, S., & Wang, Y. (2018) · Future Virology · doi:10.2217/fvl-2017-0111 · Cited by 4
Fujii, N., McGarr, G. W., Hatam, K., Chandran, N., Muia, C. M., Nishiyasu, T., Boulay, P., Ghassa, R., & Kenny, G. P. (2019) · Microcirculation · doi:10.1111/micc.12541 · Cited by 5
Nontraditional approaches to the synthesis of some biologically active substituted p-benzoquinones
Batra, M. K., Batra, C., & Ojha, K. G. (2008) · Medicinal Chemistry Research · doi:10.1007/s00044-008-9101-8 · Cited by 4
Emerging Molecular Therapies: Drugs Interfering with Signal Transduction Pathways
Baird, R. D., & Workman, P. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_18 · Cited by 4
Peterson, L. B. (2012) · KU ScholarWorks (The University of Kansas) · Cited by 6
Rational Drug Design of Small Molecule Anticancer Agents: Preclinical Discovery
Collins, I., Molife, R., Kaye, S. B., & Workman, P. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap96.pub2 · Cited by 5
Generation of a novel anti-geldanamycin antibody
Barzilay, E., Ben‐Califa, N., Shahar, M., Kashman, Y., & Neumann, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.014 · Cited by 4
Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ6
Li, J., Shi, F., Xiong, B., & He, J. H. (2015) · Worldwide Protein Data Bank · doi:10.2210/pdb5cf0/pdb · Cited by 4
Wang, X., Yu, X.-F., Li, S.-M. A., Han, R.-X., Wang, L., Wu, J., Wu, Y., He, J., Liu, B., Tsui, W. M. S., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157151 · Cited by 3
Lezama, R. A., García, A. G., Ramírez, K. L., Vela‐Ojeda, J., Maldonado, E. R., & Victoria-Avila, Z.-L. (2025) · Expert Review of Hematology · doi:10.1080/17474086.2025.2574713 · Cited by 5
Basolateral expression of GRP94 in parietal cells of gastric mucosa
Arin, R. M., Rueda, Y., Casis, Ó., Gallego, M., Vallejo, A. I., & Ochoa, B. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914010027 · Cited by 3
The Hsp90 Chaperone Machinery: An Important Hub in Protein Interaction Networks
Radons, J. (2016) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2016/24631 · Cited by 4
Detecting Posttranslational Modifications of Hsp90 Isoforms
Sager, R., Backe, S. J., Neckers, L., Woodford, M. R., & Mollapour, M. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3342-7_11 · Cited by 3
Lima, C. R., Antunes, D., Caffarena, E. R., & Carels, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168782 · Cited by 3
Gündüz, H., Kumbaracı, V., Özkılıç, Y., Tüzün, N. Ş., & Talınlı, N. (2019) · ChemistrySelect · doi:10.1002/slct.201901403 · Cited by 3
Structural Basis of Parasitic HSP90 ATPase Inhibition by Small Molecules
Tassone, G., Mazzorana, M., & Pozzi, C. (2022) · Pharmaceuticals · doi:10.3390/ph15111341 · Cited by 3
Atatreh, N., Barraclough, J., Welman, A., Cawthorne, C., Bryce, R. A., Dive, C., & Freeman, S. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701485760 · Cited by 3
Vrba, J., & Modrianský, M. (2004) · Biomedical Papers · doi:10.5507/bp.2004.025 · Cited by 3
Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition
Yang, Q., Puhm, F., Freissmuth, M., & Nanoff, C. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3390-x · Cited by 3
Emerging Role of Structural and Systems Biology in Anticancer Therapeutics
Alam, M., Naqvi, A. A. T., & Hassan, M. I. (2022) · Springer eBooks · doi:10.1007/978-981-19-1953-4_5 · Cited by 4
Pharmacologically Active Agents of Microbial Origin
Wrigley, S. K. (2014) · ASM Press eBooks · doi:10.1128/9781555817770.ch32 · Cited by 3
Structural Basis of Hsp90 Function
Prodromou, C., & Pearl, L. H. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739689-00037 · Cited by 3
Self-citationAntiviral activity of geldanamycin and its derivatives against influenza virus
Taechowisan, T., Samsawat, T., Puckdee, W., & Phutdhawong, W. S. (2020) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2020.104014 · Cited by 3
Snader, K. M. (2005) · CRC Press eBooks · doi:10.1201/9781420039658.ch18 · Cited by 3
Emerging Molecular Therapies: Drugs Interfering With Signal Transduction Pathways
Reid, A. H. M., Baird, R. D., & Workman, P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_17 · Cited by 3
Yu, J., Jiang, B., Xiong, J., Xu, X., Xu, L., Jiang, Y., & Lu, H. (2026) · Pathogens · doi:10.3390/pathogens15060629 · Cited by 2
“The upc2 ∆ / upc2 ∆ mutant exhibits increased sensitivity to three drugs associated with Ca 2+ homeostasis, including geldanamycin, an Hsp90 inhibitor [37,38], and the calcineurin inhibitors cyclosporine A and tacrolimus [39,40] (Figure 1a).”
Sinha, P. D., Islam, S., Biswas, P., & Stuehr, D. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110772 · Cited by 3
Heat Shock Protein 90: From Molecular Chaperone Function to Therapeutic Targeting in Malignancies
Zhang, B., Zou, X., Zhou, J., Sun, Q., & Chen, D. (2026) · Advanced Science · doi:10.1002/advs.75895 · Cited by 2
Stereoselective total synthesis of the antiplasmodial resorcylic acid lactone paecilomycin F
Mahankali, B., & Pabbaraja, S. (2015) · ARKIVOC · doi:10.3998/ark.5550190.p009.183 · Cited by 2
Şirin, S., & Dolanbay, S. N. (2024) · Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi · doi:10.18016/ksutarimdoga.vi.1490753 · Cited by 3
Mohamed, H. M., Elsammani, T. O., Omar, A. M., Mohamed, G. A., Abdallah, H. M., Abdulaal, O. M., & Ibrahim, S. R. M. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106997 · Cited by 2
Rai, S., Ray, S. K., & Mukherjee, S. (2026) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2025-0278 · Cited by 2
The many roles of molecular chaperones and co-chaperones in tumour biology.
Ďurech, M., Vojtěšek, B., & Muller, P. (2012) · PubMed · Cited by 2
Chaperone Suppression of Aggregated Protein Toxicity
Wacker, J. L., & Muchowski, P. J. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_8 · Cited by 2
Molecular dynamics analyses of the dissociation process of ADP from Hsp90
Kawaguchi, K., Takagi, H., Iwayama, M., Nishimura, M., Miyakawa, T., Saito, H., Takasu, M., & Nagao, H. (2012) · International Journal of Quantum Chemistry · doi:10.1002/qua.24229 · Cited by 6
Jia, J., Liu, F., Xu, X., Guo, X., Jiang, F., Huang, H., Pan, Y., Cherfaoui, B., Sun, H., & You, Q. (2014) · Molecular Informatics · doi:10.1002/minf.201300182 · Cited by 2
How Important is to Account for Water When Modeling Biomolecular Complexes
Yunta, M. J. R. (2015) · American Journal of Modeling and Optimization · doi:10.12691/ajmo-3-3-2 · Cited by 2
Regulation of Telomerase Through Transcriptional and Posttranslational Mechanisms
Depcrynski, A., Sachs, P. C., Elmore, L. W., & Holt, S. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_3 · Cited by 2
Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment
Kaur, P., Singh, T., Galukande, M., Krishnan, S., & Asea, A. A. A. (2015) · Heat shock proteins · doi:10.1007/978-3-319-17211-8_8 · Cited by 2
Development of a FRET-based High-Throughput Screening System for the Discovery of Hsp90 Inhibitors
Oh, S., Ko, Y., Lee, H., Kim, J., Chung, Y., & Park, S. B. (2011) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2011.32.9.3229 · Cited by 2
Li, J., Sun, L.-H., Xu, C., Yu, F., Zhou, H., Tang, L., & He, J. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2011.00611 · Cited by 2
Hsp90 Structure and Function in Cancer
Faridi, N., & Ghahghaei, A. (2018) · Gene Cell and Tissue · doi:10.5812/gct.81887 · Cited by 2
Therapeutic Implications of Heat Shock Proteins in Cancer
Shevtsov, M. A., & Multhoff, G. (2019) · Heat shock proteins · doi:10.1007/978-3-030-02254-9_11 · Cited by 2
Clarke, P. A., Powers, M. V., & Workman, P. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch37 · Cited by 2
Garcia-Echeverria, C. (2007) · Topics in medicinal chemistry · doi:10.1007/7355_2006_005 · Cited by 2
PDRG 1 is essential for early plant development as a component of the prefoldin‐like complex
Hernández‐Villa, L., Palacios‐Abella, A., Gómez‐Mínguez, Y., Rojas, C. C., Minguet, E. G., & Alabadı́, D. (2025) · FEBS Letters · doi:10.1002/1873-3468.70024 · Cited by 1
Lv, L., Su, Y., Chen, S., Su, W., Yin, Y., Ning, P., Liu, S., Yuan, W., & Li, L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s600992 · Cited by 1
STRUCTURE-BASED DRUG DESIGN AND ITS CONTRIBUTIONS TO CANCER CHEMOTHERAPY
Jackson, R. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50011-5 · Cited by 1
Cancer and Virus Leads by HTS, Chemical Design and SEA Data Mining
Thepchatri, P., Min, J., Ganesh, T., Du, Y., Lewis, I., Kurtkaya, S., Prussia, A. J., Li, L., Sneed, B., Plemper, R. K., et al. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789753581 · Cited by 1
Radicicol, a Hsp90 inhibitor, inhibits intestinal inflammation and leakage in abdominal sepsis
Shebrain, S., & Ramjit, A. L. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2012.12.049 · Cited by 1
GPC Spin Column HPLC–ESI-MS Methods for Screening Drugs Noncovalently Bound to Proteins
Siegel, M. M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-244-5_15 · Cited by 2
Step IIIb: The Drug-Like Chemical Diversity Pool: Diverse and Targeted Compound Collections
Seneci, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-099420-8.00004-3 · Cited by 1
Nicchitta, C. V. (2006) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000645.01 · Cited by 1
A Convergent Approach to Resorcinolic Macrolides to Expand Structural Diversity
Lombera, J. M. M., Feng, X., Shu, X., & Seiple, I. B. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202501509 · Cited by 1
Diezmann, S., & Cowen, L. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1130-1_8 · Cited by 1
Structure-Based Ligand Design I
Sun, H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100098-4.00002-8 · Cited by 1
Hsp90 Inhibitors are Promising Radiosensitizers for Radiotherapy
Kubota, N., & Matsumoto, Y. (2012) · Thermal Medicine · doi:10.3191/thermalmed.28.53 · Cited by 1
A High-Throughput Screen for Inhibitors of the Hsp90-Chaperone Machine
Davenport, J., Galam, L., & Matts, R. L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7477-1_7 · Cited by 1
Screening Technique for Heat Shock Protein 90 Inhibitors from Natural Products
Hu, Y., Zhang, X. J., Yang, X. T., Tang, Y. Y., Hu, L. Y., & Zhu, D. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_19 · Cited by 1
Hsp90 as Drug Target Against Bacterial and Fungal Infections
Islam, M. W., Bloukh, S. H., Edis, Z., & Gacem, S. A. (2020) · Current Chemical Biology · doi:10.2174/2212796814666200309113100 · Cited by 2
SAR study on inhibitors of Hsp90α using machine learning methods
Zhang, Z., Tian, Y., & Yan, A. (2021) · CCF Transactions on High Performance Computing · doi:10.1007/s42514-021-00084-7 · Cited by 1
Abdellattif, M. H., Elkamhawy, A., & Nada, H. (2022) · Heterocycles · doi:10.3987/com-21-14535 · Cited by 1
Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_7 · Cited by 1
Natural and Synthetic Inhibitors of Heat Shock Protein 90 Chaperone in Cancer Treatment
Ravula, S., Akula, S., & Kancha, R. K. (2024) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.2.45 · Cited by 1
More, M. K. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i3.6474 · Cited by 1
FRET Assays for the Identification of C. albicans HSP90-Sba1 and Human HSP90α-p23 Binding Inhibitors
Kohlmann, P., Krylov, S. N., Marchand, P., & Jose, J. (2024) · Pharmaceuticals · doi:10.3390/ph17040516 · Cited by 1
HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions
Powers, M. V., & Workman, P. (2009) · Springer eBooks · doi:10.1007/978-1-4020-8526-0_7 · Cited by 1
HSP90 inhibitors: targeting the cancer chaperone for combinatorial blockade of oncogenic pathways
Sharp, S. Y., Jones, K., & Workman, P. (2008) · Elsevier eBooks · doi:10.1016/b978-012369448-5.50016-1 · Cited by 3
PlasmodiumHsp90 as an Antimalarial Target
Prasad, G. S., Cosford, N. D. P., & Barik, S. (2011) · Wiley eBooks · doi:10.1002/9783527633883.ch23 · Cited by 1
Regulation of heat shock factor 1 (HSF1) DNA-binding and transcription
Mercier, P. A. (2003) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
Wang, Y. (2012) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Oncologic, Endocrine & Metabolic Emerging drugs in B-cell non-Hodgkin's lymphoma
Kassam, S., & Montoto, S. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.2.323 · Cited by 1
Autonomous variability: phenomenon and possible mechanisms
Tikhodeyev, O. N., & Zhurina, T. V. (2004) · Ecological genetics · doi:10.17816/ecogen223-10 · Cited by 1
Refolding activity of bacterial Hsp90 in vivo reveals ancient chaperoning functionPreprint
Luengo, T. M., Ahlnäs, T., Hoekstra, A. T., Berkers, C. R., Mayer, M. P., & Rüdiger, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462549 · Cited by 1
The Development of Organelle-localized Hsp90 Isoform-selective Inhibitors
Crowley, V. M. (2017) · KU ScholarWorks (University of Kansas) · Cited by 1
Metadata
- Authors
- Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H.
- Affiliations
- University College London (GB)
- Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, U.K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-01-01
- Volume
- 42
- Issue
- 2
- Pages
- 260-266
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2042699875
- Cited by
- 1,004
- References
- 26
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 17 · 2022: 24 · 2021: 23 · 2020: 38 · 2019: 45 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 43 · 2014: 47 · 2013: 31 · 2012: 50
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- HSP90, molecular chaperones, geldanamycin, radicicol, antitumor antibiotics, ATPase inhibition, protein folding
- MeSH terms
- Adenosine Diphosphate, Adenosine Triphosphatases, Antibiotics, Antineoplastic, Calorimetry, Lactones, Models, Molecular, Quinones, Structure-Activity Relationship, Benzoquinones, Crystallography, X-Ray, Molecular Mimicry, HSP90 Heat-Shock Proteins, Macrolides, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.